Literature DB >> 28035582

Endothelial Dysfunction and Hypertension.

Dildar Konukoglu1, Hafize Uzun2.   

Abstract

In the past, endothelium was thought to be only a mechanical barrier. Today, endothelium is known to be a tissue regulating vascular tone, cell growth and the interaction between the leukocytes, thrombocytes and the vessel wall. It also synthesizes growth factors and thrombo-regulatory molecules and responds to physical and chemical signals. Even though the term "endothelial dysfunction" is generally used for deterioration of endothelium-dependent vasodilatation; the term also includes the abnormalities between endothelium and leukocytes, thrombocytes and regulatory molecules and conditions resulting in aberrant endothelium activation. Healthy endothelium is essential for cardiovascular control. Thus, it plays an important role in pathogenesis of many diseases and cardiovascular problems such as atherosclerosis, systemic and pulmonary hypertension, cardiomyopathies and vasculitides. The aim of this chapter is to explain endothelial dysfunction and the circulating molecules of endothelial cells as they become potential targets of therapeutic approach for hypertension. This chapter reviews the roles of endothelial dysfunction in hypertension by addressing (1) the nature of endothelial function, (2) mechanisms of endothelial dysfunction and its relationship with the diseases (3) also endothelial function testing (4) the role of endothelial dysfunction and hypertension and (4) the effects of antihypertensive therapeutic options on the endothelial dysfunction. In addition to these, the role of endothelial dysfunction in white coat hypertension has been discussed. The key connections between hypertension and endothelial dysfunction are vitally important for future studies to permit new interventions to be designed and released.

Entities:  

Keywords:  Atherosclerosis; Coagulation; Endothelial dysfunction; Endothelium‐derived contracting factors: angiogenesis; Endothelium‐derived relaxing factors; Fibrinolysis; Hypertension; Inflammatory mediators; White coat hypertension

Mesh:

Substances:

Year:  2017        PMID: 28035582     DOI: 10.1007/5584_2016_90

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  101 in total

1.  Effects of Oral Magnesium Supplementation on Vascular Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Bianca Cristina Antunes Alves Marques; Márcia Regina Simas Torres Klein; Michelle Rabello da Cunha; Samanta de Souza Mattos; Lívia de Paula Nogueira; Tainah de Paula; Flávia Miranda Corrêa; Wille Oigman; Mario Fritsch Neves
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-12-16

Review 2.  Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?

Authors:  Lia E Taylor; Lindsey A Ramirez; Jacqueline B Musall; Jennifer C Sullivan
Journal:  Br J Pharmacol       Date:  2019-08-19       Impact factor: 8.739

Review 3.  Extracellular Vesicle-Mediated Vascular Cell Communications in Hypertension: Mechanism Insights and Therapeutic Potential of ncRNAs.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-22       Impact factor: 3.727

4.  Preconception Blood Pressure and Its Change Into Early Pregnancy: Early Risk Factors for Preeclampsia and Gestational Hypertension.

Authors:  Carrie J Nobles; Pauline Mendola; Sunni L Mumford; Robert M Silver; Keewan Kim; Victoria C Andriessen; Matthew Connell; Lindsey Sjaarda; Neil J Perkins; Enrique F Schisterman
Journal:  Hypertension       Date:  2020-08-03       Impact factor: 10.190

5.  Relationship between thyroid function and elevated blood pressure in euthyroid adults.

Authors:  Yeqing Gu; Lixiao Zheng; Qing Zhang; Li Liu; Ge Meng; Zhanxin Yao; Hongmei Wu; Yang Xia; Xue Bao; Hongbin Shi; Honglei Wang; Haiyan Xu; Shaomei Sun; Xing Wang; Ming Zhou; Qiyu Jia; Kun Song; Kaijun Niu
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-08       Impact factor: 3.738

Review 6.  The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review.

Authors:  Qinchao Wu; Baochen Bai; Chao Tian; Daisong Li; Haichu Yu; Bingxue Song; Bing Li; Xianming Chu
Journal:  Cardiovasc Drugs Ther       Date:  2021-04-13       Impact factor: 3.727

7.  Impaired Endothelial Function in Patients With Postural Tachycardia Syndrome.

Authors:  Abby H Chopoorian; Amr Wahba; Jorge Celedonio; Victor Nwazue; Emily C Smith; Emily M Garland; Sachin Paranjape; Luis E Okamoto; Bonnie K Black; Italo Biaggioni; Satish R Raj; Alfredo Gamboa
Journal:  Hypertension       Date:  2021-01-25       Impact factor: 10.190

8.  Early or late pregnancy loss and development of clinical cardiovascular disease risk factors: a prospective cohort study.

Authors:  J Horn; L J Tanz; J J Stuart; A R Markovitz; G Skurnik; E B Rimm; S A Missmer; J W Rich-Edwards
Journal:  BJOG       Date:  2018-09-23       Impact factor: 6.531

Review 9.  Obstructive Sleep Apnea as a Cardiovascular Risk Factor-Beyond CPAP.

Authors:  Joshua M Bock; Soumya Vungarala; Shahid Karim; Virend K Somers
Journal:  Can J Cardiol       Date:  2021-02-19       Impact factor: 5.223

10.  Aqueous extract of Whitmania pigra Whitman ameliorates ferric chloride-induced venous thrombosis in rats via antioxidation.

Authors:  Peng Li; Bingqing Lin; Ping Tang; Yuxin Ye; Zhongrui Wu; Shuhua Gui; Yaxian Zhan; Wei Yang; Baoqin Lin
Journal:  J Thromb Thrombolysis       Date:  2020-11-17       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.